Grifols SA (GRFS)
8.14
-0.05
(-0.61%)
USD |
NASDAQ |
May 21, 13:35
Grifols Price : 8.14 for May 21, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cellectis SA | 3.485 |
| Biodexa Pharmaceuticals Plc | 3.245 |
| Amarin Corp. Plc | 14.58 |
| Akari Therapeutics Plc | 4.81 |
| NuCana Plc | 1.93 |
Price Related Metrics
| PE Ratio | 11.51 |
| PS Ratio | 0.6424 |
| PEG Ratio | 0.0887 |
| Price to Book Value | 2.322 |
| Price to Free Cash Flow | 8.141 |
| Earnings Yield | 8.69% |
| Market Cap | 5.540B |
| PEGY Ratio | 0.0873 |
| Operating PE Ratio | 3.903 |
| Normalized PE Ratio | 12.03 |